Precision medicine: Sustained response to erdafitinib in FGFR2-mutant, multiply recurrent ameloblastoma

Lawson-Michod, KA; Le, CH; Tranesh, G; Thomas, PC; Bauman, JE

Bauman, JE (通讯作者),GW Canc Ctr, 800 22nd St NW,Suite 8000, Washington, DC 20052 USA.

CANCER REPORTS, 2022; 5 (10):

Abstract

Background: Ameloblastoma imposes significant morbidity and high-recurrence rates following surgery and radiation therapy. Although 89% of cases harbo......

Full Text Link